📰 Neil Goldenberg News
Neil Goldenberg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Neil Goldenberg. Real-time updates on events, politics, business and more.
July 29, 2022
/PRNewswire/ -- TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today...
January 11, 2022
This landmark trial, led by Neil Goldenberg, M.D., Ph.D., associate dean for research, and the Clinical Coordinating Center team in the Johns Hopkins All Children’s Institute for Clinical and Translational Research, focused on the emerging pediatric challenge of venous thromboembolism (VTE—also known as “blood clots,” including deep vein thrombosis (DVT) and pulmonary embolism (PE)).
January 11, 2022
Kids-DOTT trial supports fewer injections for children
January 11, 2022
Halving the duration of therapy is noninferior to the standard 3 months in patients younger than 21, the Kids-DOTT trial shows.
October 29, 2021
Goldenberg becomes the Perry Family Endowed Professor in Clinical and Translational Research, and Jallo is the David M. Goldenberg Family Endowed Chair in the Institute for Brain Protection Sciences.